A clinical formulation indicated for Erectile Dysfunction. Targeted vasodilatory action facilitates improved blood circulation to assist with achieving and sustaining physical intimacy.
A combination PDE5 inhibitor formulated to manage erectile dysfunction and designed to support enhanced blood flow to alleviate difficulty in achieving an erection.
Mechanism of Action
It combines sildenafil for quick action and tadalafil for long-lasting effect. Both work by inhibiting the PDE5 enzyme to relax muscles and increase penile blood flow.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
Up to 36 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Low blood pressure, Allergy to sildenafil or tadalafil
Severe Adverse Events
Priapism, Sudden hearing loss, Sudden vision loss, Severe hypotension
Common Side Effects
Headache, Flushing, Indigestion, Nasal congestion
Uncommon Side Effects
Dizziness, Muscle aches, Back pain, Vision changes
Information for Sildalist is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
